Security key
92859E108
- Security type / class
- Equity / COM
- Total 13F shares
- 1,561,327
- Total 13F value
- $628,686
- Share change
- -553,883
- Put/Call ratio
- 24%
- SEC-reported price per share
- $0.40
- Number of holders
- 24
- Value change
- -$356,154
- Number of buys
- 11
- Number of sells
- 12
Open additional details 1 more signal available
Report period
Q4 2022
Institutions
24
Top holders
10
VVOS full security history
Ownership snapshot
Full 13F holder table
Vivos Therapeutics, Inc. SEC filings
Vivos Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of VVOS - VIVOS THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Gurdev Dave Singh
Disclosed value leader
Gurdev Dave Singh
Comparable rows
0/15
Latest evidence
30 Sep 2022
3/4/5
13F
Highest disclosed value: $1,728,844
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Gurdev Dave Singh has the largest disclosed position value at $1.73M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Gurdev Dave Singh's linked filing trail.
Disclosed position value
Top 5
Gurdev Dave Singh
$1.73M
VANGUARD GROUP INC
$475K
Russell Investments Group, Ltd.
$236K
BARD ASSOCIATES INC
$141K
GEODE CAPITAL MANAGEMENT, LLC
$131K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Gurdev Dave Singh |
3/4/5
Chief Medical Officer, Director, 10%+ Owner
|
—
mixed-class rows
|
$1,728,844
3,266,372 shares
mixed-class rows
|
— | 05 Aug 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$475,000
731,378 shares
|
— | 30 Sep 2022 |
| Russell Investments Group, Ltd. |
13F
Company
|
—
denominator unverified
|
$236,000
365,901 shares
|
— | 30 Sep 2022 |
| BARD ASSOCIATES INC |
13F
Company
|
—
denominator unverified
|
$141,000
216,704 shares
|
— | 30 Sep 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$131,000
202,405 shares
|
— | 30 Sep 2022 |
| Boston Partners |
13F
Company
|
—
denominator unverified
|
$51,000
78,454 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
1,561,327
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
25
Q4 2022 holders
24
Holder diff
-1
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|